Leukemia and Lymphoma Research Group (LLRG)

Home >> Cancer Genomic Research Program >> Leukemia and Lymphoma Cancer Research Group

        Leukemia represents the third most common malignancy in males in the Kingdom of Saudi Arabia (Cancer Registry Report, published 2007). The overall agenda of the Leukemia Research Group (LRG) is to understand the biological mechanisms involved in leukemia and how these mechanisms can be exploited to develop and test new therapies.

       Research in the LRG is moving from single gene mutation detection approach to genomic and multi-parametric evaluation with the use of high throughput techniques, use of cellular and animal models of leukemia in characterizing the detected mutations, proteomics and miRNA analysis. CEGMR is collaborating with internationally recognized groups working on adult leukemia.

Leukemia & Lymphoma Research Group
Dr. Fatin Al-Sayes
Department of Hematology and Oncology, King Abdulaziz University Hospital
Dr. Ghazi Damanhori
King Fahad Medical Research Center, King Abdulaziz University
Prof. Mamdooh Gari
CEGMR, King Abdulaziz University
Prof. Adel Abuzenadah
CEGMR, King Abdulaziz University
Dr. Farid Ahmed
CEGMR, King Abdulaziz University
Dr. Heba Al-kattabi
CEGMR, King Abdulaziz University
Dr.Peter Natesan Pushparaj
CEGMR, King Abdulaziz University

International Collaborator:

Prof. Kuo-Chen Chou
Gordon Life Science Institute
13784 Torrey Del Mar Drive
San Diego, CA 92130, USA


Last Update
1/12/2016 1:46:10 PM